Sun Anthony Y
President &CEO | Director
2 companies
Insider Signal Score
81
ExcellentTrades Analyzed
23
12M Win Rate
95.7%
Avg 3M Return
+11.2%
Avg 12M Return
+55.6%
Sun Anthony Y is a President &CEO at Zentalis Pharmaceuticals, Inc. with holdings across 2 companies. Recent SEC Form 4 filings include 0 buys and 60 sells.
Estimated insider holdings value: $4.4M based on current market prices.
Holdings by Company
Transaction History
Showing 10 filings
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr 5, 2022 | ZNTL Zentalis Pharmaceuticals, Inc. | President &CEO | Sell | 20,942 | $50.01 | $1,047,317.35 | -0.6% | -37.7% | -64.3% | |
| Mar 2, 2022 | ZNTL Zentalis Pharmaceuticals, Inc. | President &CEO | Sell | 20,942 | $49.98 | $1,046,649.00 | -0.4% | -51.6% | -61.6% | |
| Feb 14, 2022 | ZNTL Zentalis Pharmaceuticals, Inc. | President &CEO | Sell | 4,733 | $50.23 | $237,733.23 | -0.2% | -51.2% | -59.9% | |
| Feb 2, 2022 | ZNTL Zentalis Pharmaceuticals, Inc. | President &CEO | Sell | 20,942 | $57.77 | $1,209,891.86 | -0.3% | -54.1% | -57.7% | |
| Jan 4, 2022 | ZNTL Zentalis Pharmaceuticals, Inc. | President &CEO | Sell | 20,942 | $79.38 | $1,662,308.10 | -0.2% | -33.6% | -73.3% | |
| Dec 2, 2021 | ZNTL Zentalis Pharmaceuticals, Inc. | President &CEO | Sell | 20,942 | $77.38 | $1,620,527.29 | -0.1% | -36.2% | -72.0% | |
| Nov 2, 2021 | ZNTL Zentalis Pharmaceuticals, Inc. | President &CEO | Sell | 20,942 | $80.96 | $1,695,374.06 | -0.2% | -29.4% | -69.7% | |
| Oct 4, 2021 | ZNTL Zentalis Pharmaceuticals, Inc. | President &CEO | Sell | 26,799 | $66.33 | $1,777,706.71 | -0.7% | +20.9% | -66.8% | |
| Sep 1, 2021 | ZNTL Zentalis Pharmaceuticals, Inc. | President &CEO | Sell | 26,794 | $67.50 | $1,808,716.37 | -0.7% | +22.3% | -58.5% | |
| Aug 3, 2021 | ZNTL Zentalis Pharmaceuticals, Inc. | President &CEO | Sell | 26,794 | $50.88 | $1,363,336.74 | -0.3% | +57.8% | -41.0% |
Page 1Next →